Delivery Order SPE2DB20D9127-SPE2DB22FPPN2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,276.68 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4564153966 - RITUXAN 500 MG/50 ML VIAL 50ML, with a period of performance through April 19, 2024. This award is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with DLA, which has a ceiling value of up to $4,999,999 and...
- This federal contract award, valued at $12,276.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4566185182 - RITUXAN 500 MG/50 ML VIAL 50ML. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,207.51, is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support the medical supply needs of the U.S. Department of Defense (DoD) healthcare facilities. The contract is a firm fixed-price delivery order with no set-aside designation, and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $8,948.82 contract is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,276.68, is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, a specialized biologic medication. The contract is a firm fixed-price delivery order with no set-aside designation, awarded under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,879.94 firm fixed-price delivery order contract is for the provision of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The award is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,138.34 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, and is not set aside for any specific business category. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $45,349.78, is for the delivery of 4554820137 RITUXAN 500 MG/50 ML VIAL 50ML. The contract has no set-aside designation and is part of DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which covers...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,535.28 contract is for the delivery of 4557853423 - Rituxan 500 mg/50 ml vial, 50 ml. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a comprehensive range of...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB22FPPN2Delivery Order
The federal contract award, valued at $12,767.64, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4558400232 ! RITUXAN 500 MG/50 ML VIAL 50ML. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group, valued at $499,999,999 and valid through November 2026. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/8/22 |